|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 14/705 | |||
| A61P 35/04 | |||
| A61K 39/395 |
| (11) | Number of the document | 2379598 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10701221.3 |
| Date of filing the European patent application | 2010-01-15 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/050480 |
| Date | 2010-01-15 |
| (87) | Number | WO 2010/081890 |
| Date | 2010-07-22 |
| (30) | Number | Date | Country code |
| 145635 P | 2009-01-19 | US |
| (72) |
ANFOSSI, Nicolas, FR
GAUTHIER, Laurent, FR
MOREL, Yannis, FR
MORETTA, Alessandro, IT
PAROLINI, Silvia, IT
ROSSI, Benjamin, FR
|
| (73) |
Innate Pharma,
117, Avenue de Luminy, 13009 Marseille,
FR
|
| (54) | ANTI-KIR3D ANTIBODIES |
| ANTI-KIR3D ANTIBODIES |